Intellia Announces First Clinical Evidence from Ongoing Phase 1 Study that Nexiguran Ziclumeran (nex-z), an In Vivo CRISPR/Cas9-Based Gene Editing Therapy, May Favorably Impact Disease Progression inTransthyretin (ATTR) Amyloidosis
Consistently rapid, deep and durable reduction in serum TTR accompanied by evidence…
Ultragenyx Presents Positive Update on GTX-102 Angelman Syndrome Program at FASTs 17th Annual Global Science Summit
November 09, 2024 10:30 ET | Source: Ultragenyx Pharmaceutical Inc. Phase 1/2…
Championing mental health: IOCs blueprint for major sports events
31 October 2024 - Following the positive impact of the mental health services provided…
Rushil Decor Limited Aims for Strong Growth in FY2026, Leveraging the New Jumbo Size Laminate and Plywood Segments
AHMEDABAD, India, Nov. 4, 2024 /PRNewswire/ -- Rushil Decor Limited (BSE: 533470)…
The Winter Youth Olympic Games Gangwon 2024 as a springboard to drive positive change across the host region and country
19 September 2024 - Long before the action on the snow and ice…
Championing mental health: IOC’s blueprint for major sports events
31 October 2024 - Following the positive impact of the mental health services provided…